PTAB Upholds Patent For Medac's Arthritis Drug Injector
The Patent Trial and Appeal Board on Wednesday upheld a Medac GmbH patent covering its rheumatoid arthritis treatment Rasuvo, an auto-injector that provides highly concentrated doses of methotrexate, ending a challenge...To view the full article, register now.
Already a subscriber? Click here to view full article